Bringing down the cost of drug development
Site selection is the single most decisive step of a clinical trial. However, life science companies lack the tools
to reliably screen sites & investigators at scale. As a consequence, in any given trial, 30% of sites do not
recruit a single patient.
By accelerating clinical trials, Inato helps bring novel therapies to patients faster and at a more affordable price.